ACUSENSUS LIMITED (ACE)
Share Price Analysis and Chart

12/08/2025

1

Initiation of coverage with Speculative Buy

$1.20

26.32%

Morgans has initiated coverage of Acusensus with Speculative Buy rating and target price of $1.20.

The company has a strong position in Australia (number 2) and New Zealand, with potential for more market share gains in Australia via unit growth and expansion into new states. 

In the US and UK, the entry is in early stages and over 40 pilot programs have been completed. The forecast is for over $4m revenue growth from international business in FY25 but the broker sees potential to exceed local market revenue (over $50m now).

FY25 revenue growth is estimated at 21% in line with company guidance and FY26 at 31%.

FORECAST
Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -2.50 cents.
Morgans forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -4.10 cents.

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

10/03/2025

1

Buy

$1.50

57.89%

First half results from Acusensus were in line with expectations.

Gross profit grew 19% and the company has experienced an extended period of contracting and product development while expanding into global markets. This has resulted in a lift to operating expenditure.

Canaccord Genuity expects the business will be in a "cash burn phase" over the short to medium term but remains well capitalised.

FY25 guidance expects continued topline growth driven by new and expansion of existing contracts. Buy rating and $1.50 target unchanged.

FORECAST
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -1.00 cents.
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -1.90 cents.